Product image of Linezolid Krka (Linezolid) supplied by GNH India

Linezolid Krka

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Krka (Linezolid)

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an injection solution for intravenous use. It treats complicated skin and skin structure infections, community‑acquired bacterial pneumonia, nosocomial pneumonia and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA).

GNH India supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Linezolid is an oxazolidinone antibiotic indicated for several serious bacterial infections.
  • Complicated skin and skin structure infections: provides bacterial eradication and clinical cure in Gram‑positive infections, including MRSA.
  • Community‑acquired bacterial pneumonia: targets susceptible Streptococcus pneumoniae and other pathogens to resolve pulmonary infection.
  • Nosocomial pneumonia: effective against hospital‑acquired Gram‑positive organisms, aiding recovery.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: offers activity against resistant strains to achieve microbiological clearance.

How It Works

  • Linezolid binds to the 50S ribosomal subunit of susceptible bacteria, preventing the formation of the initiation complex for protein synthesis. By inhibiting the early stage of translation, it halts bacterial growth without affecting human ribosomes, resulting in a bacteriostatic effect against most Gram‑positive organisms, including resistant strains such as MRSA.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: transient gastrointestinal upset.
  • Diarrhea: loose stools, usually self‑limited.
  • Headache: mild to moderate intensity.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste perception.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Peripheral neuropathy: sensory changes that may be irreversible.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: metabolic disturbance in prolonged therapy.
  • Myelosuppression: bone‑marrow suppression affecting blood cells.
  • Optic neuropathy: visual disturbances that may be permanent.

Precautions & Warnings

  • Before initiating Linezolid therapy, consider the following safety measures.
  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly.
  • Concomitant serotonergic agents: avoid or closely monitor for serotonin syndrome.
  • Long‑term therapy: perform periodic complete blood counts.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Linezolid can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): potentiate serotonergic toxicity.
  • Tricyclic antidepressants: additive serotonin effects.
  • Rifampin: induces metabolism, reducing linezolid exposure.
  • Phenylpropanolamine: heightened serotonergic activity.

Moderate Interactions (Monitor Closely)

  • Warfarin: may increase INR, requiring coagulation monitoring.
  • Phenytoin: may lower linezolid concentrations.
  • Erythromycin: can raise linezolid levels, watch for toxicity.
  • NSAIDs: potential additive hematologic effects.
  • Digoxin: monitor serum levels for possible increase.

Frequently Asked Questions

Linezolid Krka is indicated for complicated skin and skin structure infections, community‑acquired bacterial pneumonia, nosocomial pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA). It is used in hospital settings where intravenous antibiotic therapy is required for these serious Gram‑positive infections.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex needed for translation. This action stops bacterial growth without affecting human ribosomes, providing a bacteriostatic effect against susceptible Gram‑positive organisms, including resistant strains such as MRSA.

The specific dosing regimen for Linezolid Krka is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and other clinical factors. Healthcare professionals set the appropriate dose and duration according to approved guidelines and individual patient needs.

Safety data for Linezolid Krka in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians must evaluate each case individually and consider alternative therapies when appropriate.

To order Linezolid Krka, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and necessary import documentation.

Linezolid offers a unique mechanism by targeting the 50S ribosomal subunit, providing activity against MRSA strains that may be resistant to beta‑lactams and glycopeptides. Unlike vancomycin, it is administered intravenously with good lung penetration and does not require therapeutic drug monitoring, making it a valuable alternative in certain clinical scenarios.

Linezolid Krka should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the solution. Maintaining the cold‑chain ensures stability and potency of the injectable formulation.

Linezolid Krka is supplied as an intravenous injection solution. It is administered by a healthcare professional through a peripheral or central vein, typically over a short infusion period as directed by the prescriber. Proper aseptic technique and infusion equipment are required for safe delivery.

Serious risks include thrombocytopenia, peripheral neuropathy, serotonin syndrome when combined with serotonergic drugs, lactic acidosis, myelosuppression, and optic neuropathy. Patients should be monitored regularly for blood‑cell counts, neurological symptoms, and signs of metabolic disturbances throughout therapy.

Linezolid Krka is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. Caution is advised for individuals taking serotonergic agents, those with pre‑existing severe bone‑marrow suppression, or patients with uncontrolled hypertension due to potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT